The emerging therapeutic role of some pharmacological antidotes in management of COVID-19
Open Access
- 20 January 2022
- journal article
- review article
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 16 (1) , 1-12
Abstract
Background: A novel RNA coronavirus was identified in January 2020 as the cause of a pneumonia epidemic affecting the city of Wuhan; it rapidly spread across China.Aim of the review: The aim is to discuss the potential efficacy of some pharmacologically known pharmacological antidotes (N-acetylcysteine; hyperbaric oxygen; deferoxamine; low-dose naloxone) for the management of COVID-19-associated symptoms and complications.Method: An extensive search was accomplished in Medline, Embase, Scopus, Web of Science, and Central databases until the end of April, 2021. Four independent researchers completed the screening, and finally, the associated studies were involved.Conclusion: The current proof hinders the experts for suggesting the proper pharmacological lines of treatment of COVID-19. Organizations, for example, WHO, should pursue more practical actions and design well-planned clinical trials so that their results may be used in the treatment of future outbreaks.Keywords
This publication has 100 references indexed in Scilit:
- The chemistry and biological activities of N-acetylcysteineBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Opioid receptors: distinct roles in mood disordersTrends in Neurosciences, 2013
- Desferrioxamine Reduces Oxidative Stress in the Lung ContusionThe Scientific World Journal, 2013
- Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn’s Disease: A Randomized Placebo-Controlled TrialDigestive Diseases and Sciences, 2011
- Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosisBrain Research, 2011
- Synthetic biology approaches in drug discovery and pharmaceutical biotechnologyApplied Microbiology and Biotechnology, 2010
- Expert Consensus Guidelines for Stocking of Antidotes in Hospitals That Provide Emergency CareAnnals of Emergency Medicine, 2009
- Low-dose naltrexone for disease prevention and quality of lifeMedical Hypotheses, 2009
- Behavioral functions of the mesolimbic dopaminergic system: An affective neuroethological perspectiveBrain Research Reviews, 2007
- Cytokines, Inflammation, and PainInternational Anesthesiology Clinics, 2007